Advances in Biotechnology: EGF for diabetic foot treatment
DOI:
https://doi.org/10.31243/mdc.uta.v5i2.1077.2021Keywords:
diabetesAbstract
According to World Health Organization statistics, the global prevalence of diabetes in adults (over the age of 18) has doubled, with a 5% increase in premature diabetes mortality. The prevalence of diabetes has increased faster in low- and middle-income countries than in high-income countries. Diabetes is a major cause of blindness, kidney failure, myocardial infarction, stroke and lower limb amputation. Annually, 1.6 million deaths have been estimated as a direct cause. Nearly half of all deaths attributable to hyperglycemia occur before age 70. We can then say that diabetes mellitus continues to have an increasing prevalence, unfailingly associated with progressive and irreversible complications.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
